LIFECORE BIOMEDICAL, INC. Accumulated Other Comprehensive Income
LIFECORE BIOMEDICAL, INC. (LFCR) had Accumulated Other Comprehensive Income of $0 as of 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-03-20
- 2023-05-28: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-02-26: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2022-11-27: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2022-08-28: Accumulated Other Comprehensive Income (Loss), Net of Tax -$286.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-05-28 | $0.00 10-K · filed 2024-03-20 |
| 2023-02-26 | $0.00 10-Q · filed 2023-06-02 |
| 2022-11-27 | $0.00 10-Q · filed 2023-03-16 |
| 2022-08-28 | -$286.00K 10-K · filed 2024-03-20 |
| 2022-05-29 | -$586.00K 10-K · filed 2024-03-20 |
| 2022-02-27 | -$712.00K 10-K · filed 2024-03-20 |
| 2021-11-28 | -$816.00K 10-K · filed 2024-03-20 |
| 2021-08-29 | -$992.00K 10-K · filed 2024-03-20 |
| 2021-05-30 | -$1.36M 10-K · filed 2024-03-20 |
| 2021-02-28 | -$1.72M 10-K · filed 2024-03-20 |
| 2020-11-29 | -$2.10M 10-K · filed 2024-03-20 |
| 2020-08-30 | -$2.50M 10-K · filed 2024-03-20 |
| 2020-05-31 | -$2.81M 10-K · filed 2021-07-29 |
| 2020-02-23 | -$832.00K 10-Q · filed 2020-04-03 |
| 2019-11-24 | -$421.00K 10-Q · filed 2020-01-02 |
| 2019-08-25 | -$548.00K 10-Q · filed 2019-10-03 |
| 2019-05-26 | $64.00K 10-K · filed 2020-08-14 |
| 2019-02-24 | $540.00K 10-Q · filed 2019-04-04 |
| 2018-11-25 | $1.14M 10-Q · filed 2019-01-07 |
| 2018-08-26 | $1.06M 10-Q · filed 2018-10-05 |
| 2018-05-27 | $1.15M 10-K · filed 2019-08-01 |
| 2018-02-25 | $915.00K 10-Q · filed 2018-04-05 |
| 2017-11-26 | $568.00K 10-Q · filed 2018-01-05 |
| 2017-08-27 | $329.00K 10-Q · filed 2017-09-28 |
| 2017-05-28 | $432.00K 10-K · filed 2018-08-09 |
| 2017-02-26 | $430.00K 10-Q · filed 2017-04-07 |
| 2016-11-27 | $327.00K 10-Q · filed 2017-01-05 |
| 2012-02-26 | -$202.00K 10-Q · filed 2012-03-28 |
| 2011-11-27 | -$235.00K 10-Q · filed 2012-01-05 |
| 2011-08-28 | -$301.00K 10-Q · filed 2011-10-05 |
| 2011-05-29 | -$267.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |